Efficacy of Danazol Versus Panadol In Management Of Resistant Mastalgia

Aim: To determine the effectiveness of Danazol versus Panadol in treatment mastalgia. Study Design: Prospective Study. Place and Duration: Combined Military Hospital, Peshawar; from February 2022 to March 2023 Methods: Total 54 women with range age 18-42 years presented this study. Female patients reproductive group moderate severe breast pain resistant cases (taken analgesia for 3 months) were included. Age, body mass index, place residence, level education marital status among many comprehensive demographics obtained after receiving informed written consent enrolled patients. Women equally divided two groups I received 100mg oral twice a day II 27 3-months. Post-treatment both was compared. SPSS 20.0 used analyze all data. Results: In females, 22 (40.7%) had 28-30 years, 18 (33.3%)cases 31-40 14 (25.9%) 41-42 years. mean BVMI 22. 11±4.28 kg/m2and BMI 21.7±6.30 kg/m2. We found significantly excellent results 21 (77.8%) terms reduction pain, as compared 15 (55.6%) P value <0.004. Frequency menstrual problem, weight gain hirsutism higher 11 9 (33.3%) but did not any significant difference. Practical implication: Effective use reduces need Panadol. Therefore, there will be decrease Overuse. Conclusion: concluded study that mastalgia effective useful retrieve less recurrence rate. Keyword: Mastalgia, Danazol, Panadol, Side Effects, Recurrence, Resistance